IMPLANT SITE CYST

IMPLANT SITE CYST was reported 27 times

IMPLANT SITE CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thiazide-like Diuretic [EPC] 2 0.0000
1 Progestin [EPC] 13 0.0000
2 Provitamin D2 Compound [EPC] 1 0.0000
3 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2 0.0000
4 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
5 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
6 Interferon beta [EPC] 2 0.0000
7 Purine Antimetabolite [EPC] 1 0.0000
8 Parathyroid Hormone Analog [EPC] 1 0.0000
9 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
10 Alkylating Drug [EPC] 1 0.0000
11 Vitamin D [EPC] 1 0.0000
12 Vitamin B12 [EPC] 1 0.0000
13 Vitamin C [EPC] 1 0.0000
14 Proton Pump Inhibitor [EPC] 1 0.0000
15 Tumor Necrosis Factor Blocker [EPC] 1 0.0000